| Product NDC: | 0299-6100 |
| Proprietary Name: | PLIAGLIS |
| Non Proprietary Name: | lidocaine and tetracaine |
| Active Ingredient(s): | 70; 70 mg/g; mg/g & nbsp; lidocaine and tetracaine |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0299-6100 |
| Labeler Name: | Galderma Laboratories, L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021717 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060629 |
| Package NDC: | 0299-6100-10 |
| Package Description: | 100 g in 1 TUBE (0299-6100-10) |
| NDC Code | 0299-6100-10 |
| Proprietary Name | PLIAGLIS |
| Package Description | 100 g in 1 TUBE (0299-6100-10) |
| Product NDC | 0299-6100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lidocaine and tetracaine |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20060629 |
| Marketing Category Name | NDA |
| Labeler Name | Galderma Laboratories, L.P. |
| Substance Name | LIDOCAINE; TETRACAINE |
| Strength Number | 70; 70 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Ester Local Anesthetic [EPC],Esters [Chemical/Ingredient],Local Anesthesia [PE] |